|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS |
a Department of Chemical Engineering,
b Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, and
c Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA;
d Instituto de Engenharia Biomédica, Porto, Portugal;
e Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA
Key Words. Human embryonic stem cells • Bone tissue engineering • Embryoid bodies • Osteogenic cell frequency • Matrix characterization
Correspondence: Robert S. Langer, Ph.D., Massachusetts Institute of Technology, 77 Massachusetts Ave., Room E25-342, Cambridge, Massachusetts 02139-4307, USA. Telephone: 617-253-3123; Fax: 617-258-8827; e-mail: rlanger{at}mit.edu
Received August 10, 2005;
accepted for publication October 20, 2005.
Osteogenic cultures of embryonic stem cells (ESCs) are predominately derived from three-dimensional cell spheroids called embryoid bodies (EBs). An alternative method that has been attempted and merits further attention avoids EBs through the immediate separation of ESC colonies into single cells. However, this method has not been well characterized and the effect of omitting the EB step is unknown. Herein, we report that culturing human embryonic stem cells (hESCs) without the EB stage leads to a sevenfold greater number of osteogenic cells and to spontaneous bone nodule formation after 1012 days. In contrast, when hESCs were differentiated as EBs for 5 days followed by plating of single cells, bone nodules formed after 4 weeks only in the presence of dexamethasone. Furthermore, regardless of the inclusion of EBs, bone matrix formed, including cement line matrix and mineralized collagen, which displayed apatitic mineral (PO4) with calcium-to-phosphorous ratios similar to those of hydroxyapatite and human bone. Together these results demonstrate that culturing hESCs without an EB step can be used to derive large quantities of functional osteogenic cells for bone tissue engineering.
This article has been cited by other articles:
![]() |
L. Duplomb, M. Dagouassat, P. Jourdon, and D. Heymann Concise Review: Embryonic Stem Cells: A New Tool to Study Osteoblast and Osteoclast Differentiation Stem Cells, March 1, 2007; 25(3): 544 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mimeault and S. K. Batra Concise Review: Recent Advances on the Significance of Stem Cells in Tissue Regeneration and Cancer Therapies Stem Cells, November 1, 2006; 24(11): 2319 - 2345. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
